Home » Metamark Genetics Nabs $10M in Financing

Metamark Genetics Nabs $10M in Financing

Sep 10, 2015
|
staff reporter

NEW YORK (GenomeWeb) – Metamark Genetics today said that it has secured $10 million in financing to further expand its clinical testing products and services in the US and abroad. 

The new funding, the company added, will allow it to complete the development of other urologic assay products. Metamark also announced that Shawn Marcell has resigned as president and CEO of the firm to pursue other opportunities. He has been replaced by Kenneth Weg, a Metamark co-founder and current chairman of the board of directors. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Skipped Steps

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

Just a Few Bats

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

This Week in Nature

In Nature this week: investigation into the genetics of medulloblastoma, and more.

Genomics for the Trees

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.

What's Popular?

In Molecular Diagnostics

  1. UPDATE: Courtagen Closes Genetic Testing Business, Citing Regulatory, Reimbursement Challenges

  2. Danaher Q2 Revenues Grow 6 Percent; MDx Product Line Shut Down

  3. NanoVelcro Microchips Can Capture Fetal Cells from Maternal Blood for Prenatal Genetic Testing

    Premium

  4. Abbott Dx Revenues Rise 4 Percent in Q2 on Strong Core Lab and Point-of-Care Growth

  5. Aetna Won't Cover Noninvasive Prenatal Testing for Average-Risk Pregnancies

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.